Need professional-grade analysis? Visit stockanalysis.com
$28.83B
40.38
22,356
1.55%
Sandoz Group AG (SDZ) trades on SIX Swiss Exchange in CHF. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CHF67.16, up 2.82% from the previous close.
Over the past year, SDZ has traded between a low of CHF32.36 and a high of CHF72.42. The stock has gained 107.5% over this period. It is currently 7.3% below its 52-week high.
Sandoz Group AG has a market capitalization of $28.83B, with a price-to-earnings ratio of 40.38 and a dividend yield of 1.55%.
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Side-by-side comparison against top Healthcare peers.